Description

TRODELVY® (sacituzumab govitecan-hziy) is a prescription medicine used to treat adults with triple-negative breast cancer (negative for estrogen and progesterone hormone receptors and HER2) that has spread to other parts of the body (metastatic) or cannot be removed by surgery, and who have received two or more prior treatments, including at least one treatment for metastatic disease.

Additional information

Brand	TRODELVY® 180
Generic name	Sacituzumab govitecan-hziy for Injection
Form	Parenteral
Strength	180mg
Manufacturer	Gilead
Documents	Either PO or prescription
Storage	2-8°C temperature
Global delivery time	10-20 days
Pay attention	Shipment should be organized from our Company with airlines only (Not FedEx, DHL, EMS, Aramex, UPS), at the specified storage condition along with one data logger.